| TMO | Thermo Fisher Scientific Inc | -- | -- | 787.01K | 7.72% | $529.24M |
| LLY | Eli Lilly & Co | -- | -- | 349.66K | 6.89% | $472.09M |
| DHR | Danaher Corp | -- | -- | 2.08M | 6.73% | $460.82M |
| NTRA | Natera Inc | -- | -- | 916.81K | 3.67% | $251.29M |
| WST | West Pharmaceutical Services Inc | -- | -- | 507.57K | 2.90% | $198.36M |
| JNJ | Johnson & Johnson | -- | -- | 690.60K | 2.74% | $187.44M |
| UNH | UnitedHealth Group Inc | -- | -- | 547.82K | 2.73% | $187.21M |
| MRK | Merck & Co Inc | -- | -- | 1.28M | 2.50% | $171.47M |
| ABBV | AbbVie Inc | -- | -- | 569.82K | 2.40% | $164.28M |
| WAT | Waters Corp | -- | -- | 336.79K | 2.18% | $149.39M |
| A | Agilent Technologies Inc | -- | -- | 870.25K | 2.16% | $148.19M |
| ALNY | Alnylam Pharmaceuticals Inc | -- | -- | 1.01M | 2.16% | $148.04M |
| TXG | 10X Genomics Inc Class A | -- | -- | 2.74M | 2.11% | $144.58M |
| ARGX | Argenx SE ADR | -- | -- | 145.86K | 1.99% | $136.17M |
| VTRS | Viatris Inc | -- | -- | 6.48M | 1.85% | $126.70M |
| RVMD | Revolution Medicines Inc | -- | -- | 737.67K | 1.75% | $119.58M |
| RGEN | Repligen Corp | -- | -- | 699.42K | 1.68% | $115.34M |
| ASND | Ascendis Pharma A/S | -- | -- | 449.88K | 1.66% | $113.92M |
| ILMN | Illumina Inc | -- | -- | 567.15K | 1.60% | $109.47M |
| GH | Guardant Health Inc | -- | -- | 704.08K | 1.48% | $101.67M |
| MRNA | Moderna Inc | -- | -- | 501.15K | 1.41% | $96.28M |
| BTSG | BrightSpring Health Services Inc | -- | -- | 1.50M | 1.36% | $93.07M |
| JAZZ | Jazz Pharmaceuticals PLC | -- | -- | 405.15K | 1.35% | $92.61M |
| DIM.PA | Sartorius Stedim Biotech | -- | -- | 348.39K | 1.23% | $84.34M |
| KNSA | Kiniksa Pharmaceuticals International Plc Class A | -- | -- | 827.70K | 1.13% | $77.59M |
| UCB.BR | UCB SA | -- | -- | 242.22K | 1.08% | $74.32M |
| ORKA | Oruka Therapeutics Inc | -- | -- | 780.86K | 1.07% | $73.30M |
| PCVX | Vaxcyte Inc | -- | -- | 1.30M | 1.07% | $73.12M |
| GILD | Gilead Sciences Inc | -- | -- | 391.00K | 0.96% | $65.58M |
| LFST | LifeStance Health Group Inc | -- | -- | 4.60M | 0.91% | $62.32M |
| SYRE | Spyre Therapeutics Inc | -- | -- | 649.45K | 0.89% | $61.16M |
| BRKR | Bruker Corp | -- | -- | 1.05M | 0.88% | $60.22M |
| COGT | Cogent Biosciences Inc | -- | -- | 2.21M | 0.87% | $59.38M |
| ELVN | Enliven Therapeutics Inc | -- | -- | 1.26M | 0.86% | $58.68M |
| RPRX | Royalty Pharma PLC Class A | -- | -- | 855.89K | 0.85% | $58.36M |
| CAI | Caris Life Sciences Inc | -- | -- | 3.17M | 0.81% | $55.13M |
| TWST | Twist Bioscience Corp | -- | -- | 497.92K | 0.76% | $51.79M |
| PRAX | Praxis Precision Medicines Inc | -- | -- | 168.67K | 0.75% | $51.26M |
| INSM | Insmed Inc | -- | -- | 340.43K | 0.71% | $48.51M |
| KYMR | Kymera Therapeutics Inc | -- | -- | 416.21K | 0.70% | $47.85M |
| HTFL | HeartFlow Inc | -- | -- | 1.02M | 0.69% | $47.26M |
| ROIV | Roivant Sciences Ltd | -- | -- | 1.21M | 0.68% | $46.81M |
| AMLX | Amylyx Pharmaceuticals Inc | -- | -- | 1.79M | 0.68% | $46.56M |
| LEGN | Legend Biotech Corp ADR | -- | -- | 2.99M | 0.66% | $45.35M |
| -- | 10X Genomics Inc Class B | -- | -- | -- | 0.66% | $45.18M |
| BIIB | Biogen Inc | -- | -- | 181.08K | 0.66% | $45.18M |
| DNTH | Dianthus Therapeutics Inc | -- | -- | 501.12K | 0.61% | $41.85M |
| MBX | MBX Biosciences Inc | -- | -- | 814.49K | 0.60% | $41.03M |
| RLAY | Relay Therapeutics Inc | -- | -- | 2.32M | 0.55% | $37.54M |
| -- | NextCure Inc | -- | -- | -- | 0.53% | $36.44M |
| ONC | BeOne Medicines Ltd ADR | -- | -- | 83.74K | 0.48% | $32.93M |
| MIRM | Mirum Pharmaceuticals Inc | -- | -- | 338.02K | 0.48% | $32.91M |
| CGON | CG oncology Inc | -- | -- | 406.06K | 0.48% | $32.61M |
| XENE | Xenon Pharmaceuticals Inc | -- | -- | 862.72K | 0.47% | $31.98M |
| VRDN | Viridian Therapeutics Inc | -- | -- | 1.01M | 0.45% | $30.89M |
| KMTS | Kestra Medical Technologies Ltd | -- | -- | 1.20M | 0.45% | $30.55M |
| MLYS | Mineralys Therapeutics Inc | -- | -- | 2.15M | 0.43% | $29.65M |
| ZBIO | Zenas Biopharma Inc | -- | -- | 1.18M | 0.42% | $29.13M |
| TARS | Tarsus Pharmaceuticals Inc | -- | -- | 383.84K | 0.41% | $28.30M |
| AXSM | Axsome Therapeutics Inc | -- | -- | 212.82K | 0.40% | $27.66M |
| VCYT | Veracyte Inc | -- | -- | 1.10M | 0.40% | $27.62M |
| PHVS | Pharvaris NV | -- | -- | 806.79K | 0.37% | $25.38M |
| IRON | Disc Medicine Inc | -- | -- | 333.06K | 0.36% | $24.87M |
| NAMS | Newamsterdam Pharma Co NV | -- | -- | 1.34M | 0.36% | $24.81M |
| EW | Edwards Lifesciences Corp | -- | -- | 218.40K | 0.33% | $22.44M |
| SRRK | Scholar Rock Holding Corp | -- | -- | 454.45K | 0.32% | $22.23M |
| BSX | Boston Scientific Corp | -- | -- | 513.65K | 0.32% | $21.82M |
| BRVE | Braveheart Bio Inc | -- | -- | 1.01M | 0.30% | $20.92M |
| GPCR | Structure Therapeutics Inc ADR | -- | -- | 1.19M | 0.28% | $19.38M |
| TRAX | First Tracks Biotherapeutics Inc | -- | -- | 452.75K | 0.28% | $19.14M |
| -- | Fidelity Cash Central Fund | -- | -- | -- | 0.28% | $18.96M |
| ELAN | Elanco Animal Health Inc | -- | -- | 720.89K | 0.27% | $18.46M |
| IRTC | iRhythm Technologies Inc | -- | -- | 194.51K | 0.27% | $18.19M |
| VKTX | Viking Therapeutics Inc | -- | -- | 705.18K | 0.26% | $17.60M |
| -- | Parabilis Medicines Inc | -- | -- | -- | 0.25% | $17.32M |
| CTMX | CytomX Therapeutics Inc | -- | -- | 8.24M | 0.24% | $16.32M |
| STOK | Stoke Therapeutics Inc | -- | -- | 610.68K | 0.24% | $16.33M |
| -- | Cleerly Inc Series C | -- | -- | -- | 0.24% | $16.34M |
| ISRG | Intuitive Surgical Inc | -- | -- | 40.30K | 0.24% | $16.27M |
| IMCR | Immunocore Holdings PLC ADR | -- | -- | 575.51K | 0.22% | $15.14M |
| OLMA | Olema Pharmaceuticals Inc | -- | -- | 2.05M | 0.21% | $14.52M |
| JBIO | Jade Biosciences Inc | -- | -- | 916.53K | 0.20% | $14.05M |
| TRVI | Trevi Therapeutics Inc | -- | -- | 1.01M | 0.20% | $13.60M |
| COR | Cencora Inc | -- | -- | 39.69K | 0.20% | $13.51M |
| SMMT | Summit Therapeutics Inc | -- | -- | 1.27M | 0.18% | $12.68M |
| -- | Synlogic Inc | -- | -- | -- | 0.17% | $11.84M |
| TYRA | Tyra Biosciences Inc | -- | -- | 569.31K | 0.17% | $11.37M |
| CVS | CVS Health Corp | -- | -- | 134.85K | 0.16% | $10.97M |
| DMRA | Damora Therapeutics Inc | -- | -- | 454.48K | 0.15% | $10.64M |
| SI | Shoulder Innovations Inc | -- | -- | 527.29K | 0.15% | $10.31M |
| CLDX | Celldex Therapeutics Inc | -- | -- | 371.75K | 0.15% | $10.21M |
| ALMR | Alamar Biosciences Inc | -- | -- | 386.22K | 0.15% | $10.22M |
| -- | Endeavor BioMedicines Inc Series C | -- | -- | -- | 0.13% | $8.91M |
| -- | Medical Microinstruments Inc/Italy Series C | -- | -- | -- | 0.13% | $8.73M |
| -- | InSightec Ltd Series G | -- | -- | -- | 0.13% | $8.65M |
| ADRX | ADARx Pharmaceuticals Inc | -- | -- | 615.43K | 0.12% | $7.98M |
| -- | Aledade Inc Series B1 | -- | -- | -- | 0.11% | $7.72M |
| CLYM | Climb Bio Inc | -- | -- | 752.49K | 0.10% | $6.92M |
| -- | Element Biosciences Inc Series C | -- | -- | -- | 0.10% | $6.92M |
| -- | CellCentric Ltd Series D | -- | -- | -- | 0.09% | $6.26M |
| -- | Kardium Inc/US Series D-7 (Aug 25 Closing) | -- | -- | -- | 0.09% | $6.20M |
| CTNM | Contineum Therapeutics Inc Class A | -- | -- | 706.32K | 0.09% | $6.04M |
| SLN | Silence Therapeutics PLC ADR | -- | -- | 275.70K | 0.08% | $5.46M |
| ANNX | Annexon Inc | -- | -- | 1.64M | 0.07% | $5.08M |
| OM | Outset Medical Inc | -- | -- | 1.63M | 0.07% | $4.56M |
| CBIO | Crescent Biopharma Inc | -- | -- | 348.90K | 0.07% | $4.50M |
| -- | Zenas Biopharma Inc | -- | -- | -- | 0.06% | $4.34M |
| UPB | Upstream Bio Inc | -- | -- | 2.47M | 0.06% | $4.22M |
| CYCN | Korsana Biosciences Inc | -- | -- | 178.98K | 0.06% | $4.21M |
| ALHC | Alignment Healthcare Inc | -- | -- | 638.50K | 0.06% | $4.08M |
| -- | Manus Bio Inc Series One-6 | -- | -- | -- | 0.06% | $4.05M |
| SEPN | Septerna Inc | -- | -- | 104.26K | 0.06% | $4.05M |
| -- | InMed Pharmaceuticals Inc | -- | -- | -- | 0.06% | $3.85M |
| -- | Advancell Pty Ltd Series D | -- | -- | -- | 0.06% | $3.75M |
| OCUL | Ocular Therapeutix Inc | -- | -- | 672.63K | 0.06% | $3.79M |
| -- | Galvanize Therapeutics Series C-1 | -- | -- | -- | 0.05% | $3.55M |
| LTGO | Latigo Biotherapeutics Inc | -- | -- | 273.02K | 0.05% | $3.55M |
| DFTX | Definium Therapeutics Inc | -- | -- | 121.96K | 0.05% | $3.50M |
| -- | Element Biosciences Inc Series D | -- | -- | -- | 0.05% | $3.43M |
| -- | Kardium Inc/US 10% 12/31/2026 | -- | -- | -- | 0.05% | $3.46M |
| -- | Element Biosciences Inc Series D1 | -- | -- | -- | 0.05% | $3.43M |
| -- | Heal Thrive Holdings LLC unit | -- | -- | -- | 0.05% | $3.31M |
| -- | dMed Biopharmaceutical Co Ltd Series C | -- | -- | -- | 0.04% | $3.07M |
| -- | Rallybio Corp | -- | -- | -- | 0.04% | $2.85M |
| -- | Asimov Inc Series B | -- | -- | -- | 0.04% | $2.73M |
| -- | Allotera Therapeutics Inc 0% 12/31/2199 | -- | -- | -- | 0.04% | $2.53M |
| -- | Aledade Inc Series E1 | -- | -- | -- | 0.03% | $2.18M |
| -- | Galvanize Therapeutics Series B | -- | -- | -- | 0.03% | $2.03M |
| COAG | Hemab Therapeutics Holdings Inc | -- | -- | 51.74K | 0.03% | $2.00M |
| IMNM | Immunome Inc | -- | -- | 124.36K | 0.03% | $1.95M |
| -- | Advancell Pty Ltd 0% 12/31/2199 | -- | -- | -- | 0.03% | $1.90M |
| -- | Epicrispr Biotechnologies Inc Series C | -- | -- | -- | 0.03% | $1.72M |
| -- | Kardium Inc/US Series D-7 (June 25 2nd Closing) | -- | -- | -- | 0.02% | $1.39M |
| -- | Galvanize Therapeutics 10% 2/28/2027 | -- | -- | -- | 0.02% | $1.37M |
| -- | Tubulis GmbH milestone 2 rights | -- | -- | -- | 0.02% | $1.32M |
| -- | Tubulis GmbH milestone 1 rights | -- | -- | -- | 0.01% | $867.52K |
| RVTY | Revvity Inc | -- | -- | 5.79K | 0.01% | $840.89K |
| -- | Saluda Medical Inc | -- | -- | -- | 0.01% | $828.40K |
| -- | Allotera Therapeutics Inc Series B | -- | -- | -- | 0.01% | $749.66K |
| -- | Tubulis GmbH milestone 4 rights | -- | -- | -- | 0.01% | $667.27K |
| -- | Tubulis GmbH milestone 3 rights | -- | -- | -- | 0.01% | $584.00K |
| -- | Tubulis GmbH milestone 6 rights | -- | -- | -- | 0.01% | $360.88K |
| -- | Medical Microinstruments Inc/Italy warrants 2/16/2031 | -- | -- | -- | 0.01% | $338.28K |
| -- | Tubulis GmbH milestone 7 rights | -- | -- | -- | 0.01% | $343.79K |
| -- | ElevateBio LLC Series C | -- | -- | -- | 0.00% | $262.55K |
| -- | Kardium Inc/US Series D-7 (June 25 1st Closing) | -- | -- | -- | 0.00% | $289.41K |
| -- | Candid Therapeutics milestone 1 rights | -- | -- | -- | 0.00% | $221.36K |
| -- | Tubulis GmbH milestone 5 rights | -- | -- | -- | 0.00% | $113.41K |
| -- | Candid Therapeutics milestone 2 rights | -- | -- | -- | 0.00% | $126.49K |
| -- | Tubulis GmbH milestone 9 rights | -- | -- | -- | 0.00% | $56.70K |
| -- | Tubulis GmbH escrow shares | -- | -- | -- | 0.00% | $43.17K |
| -- | Tubulis GmbH milestone 8 rights | -- | -- | -- | 0.00% | $56.70K |
| -- | Tubulis GmbH milestone 10 rights | -- | -- | -- | 0.00% | $26.81K |
| -- | Epicrispr Biotechnologies Inc warrants 8/10/2028 | -- | -- | -- | 0.00% | $150 |
| -- | Tubulis GmbH milestone 11 rights | -- | -- | -- | 0.00% | $25.34K |
| -- | Candid Therapeutics Shareholder Rep Escrow shares | -- | -- | -- | 0.00% | $32 |
| -- | Candid Therapeutics Adjustment Escrow shares | -- | -- | -- | 0.00% | $31.62K |
| -- | Korsana Biosciences Inc rights | -- | -- | -- | 0.00% | $16.11K |